Bladder cancer vaccine (Thomas Jefferson)

N/A

Report date: 2024/12/11 10:25:34

Base Information

Drug NameBladder cancer vaccine (Thomas Jefferson)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSkin Melanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesThomas Jefferson University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSidney Kimmel Cancer Center At Thomas Jefferson University
Active IndicationsN/A
Inactive IndicationsSkin Melanoma

Other Information

ATC CodeN/A
Related LinksN/A